News
When Do Patient-Reported Outcome Measures Inform Readmission Risk?
Clinical question: Among patients discharged from the hospital, how do patient-reported outcome (PRO) measures change after discharge, and can...
Clinical question: Among patients discharged from the hospital, how do patient-reported outcome (PRO) measures change after discharge, and can...
Clinical question: Is there a standardized way to identify doctors at high risk of incurring repeated medicolegal events? Background: Medicolegal...
LUGANO—The phase 1, first-in-human study of the novel SYK inhibitor TAK-659 is showing “good early evidence” of antitumor activity in patients...
Photo courtesy of The Wistar Institute Although PI3K inhibitors have been designed to treat cancer, new research indicates these drugs may...
TORONTO—When children with hemophilia develop inhibitors, their caregivers shoulder a greater burden, according to a pilot study. Researchers...
Key clinical point: A magnetic device designed to augment the lower esophageal sphincter is a surgical option that can be expected to provide...